Tandem’s New Pint-Sized Insulin Pump

Looking to recover from a relatively lackluster second quarter in terms of meeting its lofty goals for returns, San Diego-based Tandem Diabetes has locked in a multi-quarter-spanning readjustment plan. The company’s second quarter was rendered a disappointment due to a previously set, optimistic 2022 benchmark for estimated revenue despite a 16% uplift from the same period a year prior...